What is the recommended starting dose of lisdexamfetamine (Vyvanse) for stimulant‑naïve patients (children ≥6 years and adults)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Starting Dose for Vyvanse

For stimulant-naïve patients, start lisdexamfetamine (Vyvanse) at 20-30 mg once daily in the morning for both children (≥6 years) and adults.

Dosing Algorithm

Initial Dosing

  • Starting dose: 20-30 mg once daily 1
  • Administer in the morning
  • Can be taken with or without food (though food delays peak effect by ~1 hour) 2

Titration Schedule

  • Increase by 10 mg weekly until optimal response is achieved 1
  • Maximum dose: 70 mg daily 1, 2
  • Continue weekly increases based on symptom control and tolerability

Important Context from General Amphetamine Guidelines

While the provided guidelines [3-3-3] recommend starting immediate-release dextroamphetamine/amphetamine at 2.5 mg for children and 5 mg for adults, these recommendations apply to immediate-release formulations, not to Vyvanse. Lisdexamfetamine is a prodrug with unique pharmacokinetics—it requires enzymatic conversion in red blood cells to active dextroamphetamine, resulting in a gradual, extended release profile 2.

The 20-30 mg starting dose for Vyvanse reflects this prodrug design and once-daily extended-release formulation, which provides approximately 12-14 hours of symptom control 4, 5, 6.

Pre-Treatment Requirements

Before initiating Vyvanse:

  • Obtain baseline vital signs: blood pressure, pulse, height, and weight [3-3]
  • Cardiovascular screening: Document any personal or family history of cardiac disease, sudden death, or arrhythmias 7
  • Document prior treatments: Previous medications, psychosocial interventions, and their responses [3-3]

Monitoring During Titration

  • Weekly contact (office visit or phone) during dose adjustments 3
  • Assess ADHD symptoms using rating scales from parents/teachers (children) or self-report (adults) 3
  • Monitor for adverse effects: decreased appetite, insomnia, irritability, headache 5, 6, 8
  • Check vital signs at each dose increase

Special Populations

Preschool Children (Ages 4-5)

  • Start at 5 mg daily if treatment is necessary 8
  • This age group shows smaller effect sizes and requires careful risk-benefit assessment
  • Only consider if moderate-to-severe dysfunction persists after behavioral interventions 7

Adults

  • Same starting dose as older children: 20-30 mg once daily 1
  • May require full 70 mg dose to cover longer working day 3

Common Pitfalls to Avoid

  1. Don't start too low: Unlike immediate-release amphetamines (2.5-5 mg), Vyvanse's prodrug formulation requires 20-30 mg to achieve therapeutic effect
  2. Don't titrate too quickly: Weekly increases allow proper assessment of response and tolerability
  3. Don't confuse with immediate-release guidelines: The older guidelines [3-3] reference immediate-release formulations with different pharmacokinetics
  4. Don't skip cardiovascular screening: Stimulants carry cardiovascular risks requiring baseline assessment [3-3,7]

Safety Profile

Most common adverse effects (>10% incidence):

  • Decreased appetite (most common) 5, 6, 8
  • Insomnia
  • Headache
  • Dry mouth

Expected cardiovascular changes:

  • Modest increases in pulse (mean +2.7 bpm) and blood pressure (systolic +1.0 mmHg, diastolic +1.7 mmHg) 8
  • Monitor quarterly in adults, annually in children [3-3]

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.